A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia

Anamorelin (ANA) is approved for treating cancer cachexia (CCX) in Japan. We report the case of a 69-year-old man with stage IVB squamous cell lung cancer complicated by CCX, having a 13.6% weight loss in 6 months. After chemotherapy was initiated, his weight was further reduced. Therefore, we start...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshima, Yuri, Matsuura, Hiroyuki, Sakurai, Yusuke, Hirai, Kaho, Tani, Eriko, Yoshimoto, Naoki, Minami, Kenichi, Yamasaki, Fumio, Nishime, Mayu, Hirashima, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866093/
https://www.ncbi.nlm.nih.gov/pubmed/35242522
http://dx.doi.org/10.1016/j.rmcr.2022.101609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866093/
https://www.ncbi.nlm.nih.gov/pubmed/35242522
http://dx.doi.org/10.1016/j.rmcr.2022.101609

Ejemplares similares